What to Know About Thyroid Eye Disease (Graves’ Ophthalmopathy)

Here’s what to know about this eye condition.
What Is Thyroid Eye Disease?
As antibodies attack cells on the eyes called orbital fibroblasts, they release inflammatory substances called cytokines, explains Andrea Kossler, MD, an associate professor of ophthalmology at Stanford University School of Medicine in Palo Alto, California, and a thyroid eye disease specialist. “This causes pain, swelling, and redness in the eyes,” she says.
Common Symptoms of Thyroid Eye Disease
- Bags under the eyes
- Blurred or double vision
- Bulging/staring eyes
- Decreased eye motility (movement)
- Dry eyes
- Gritty feeling in the eyes
- Low tolerance to bright lights
- Pain
- Redness
- Swelling
- Tearing
How Is Thyroid Eye Disease Diagnosed and Monitored?
“Thyroid eye disease is commonly misdiagnosed,” says Kossler. “It can take moderate or severe disease before it’s correctly diagnosed.” If you notice common signs and symptoms, such as eye pain, redness, swelling, or a change in the appearance of your eyes, she recommends seeing an ophthalmologist to get lab work done to rule out thyroid eye disease.
How Is Thyroid Eye Disease Treated?
There are several treatment options for thyroid eye disease. “If you have thyroid eye disease, it’s extremely important to see your endocrinologist to get your thyroid under control,” says Kossler. While this does not treat thyroid eye disease itself, she says, it’s an important first step.
- Selenium plays a key role in thyroid function. Research has found selenium supplements to be beneficial in the management of mild eye disease. Taking this antioxidant supplement may help decrease the progression of thyroid eye disease in people who have mild-to-moderate forms of the condition, says Kossler. Your doctor may also recommend eating Brazil nuts, which are naturally rich in the mineral.
- Artificial tears can help relieve dry eye and redness.
- Dark sunglasses can ease the effects of light sensitivity.
- Fresnel prisms can help address double vision.
- Steroids can help decrease inflammation, puffiness, and swelling.
- Radiation can decrease inflammation of the tissue in the eye socket, but its effectiveness in thyroid eye disease remains uncertain. One review found that radiation can improve some symptoms of thyroid eye disease, but more research is needed.
- Surgery can correct eye and eyelid position.
- An intravenous infusion can help prevent inflammation and decrease proptosis (eye bulging).
The treatment that’s right for you will depend on whether you have a mild, moderate, or severe case of the disease, says Kossler. Your doctor will also take your personal health history into consideration.
Thyroid eye disease sometimes subsides on its own, without treatment, she says, so doctors will take a watch-and-wait approach with some people. If the symptoms of thyroid eye disease are interfering with your quality of life, your doctor may recommend using artificial tears.
Potential Complications
Research and Advances
Teprotumumab is a major advancement in the treatment of thyroid eye disease. It is a monoclonal antibody that has been shown to improve double vision, reduce proptosis, and reverse the restructuring of orbital tissue caused by thyroid eye disease.
- RVT-1401, a monoclonal antibody that may reduce proptosis and slow the overproduction of thyroid hormones
- Statins, which studies have shown can improve double vision and eyelid opening
- Belimumab, a monoclonal antibody that can improve overall thyroid eye disease symptoms
- Local injection of corticosteroid into the eye socket to reduce inflammation and pain
- Anti–vascular endothelial growth factor, which decreases the blood vessel density associated with thyroid eye disease
- VRDN-001, a monoclonal antibody similar to teprotumumab, but with more convenient dosing
Discuss the options with your ophthalmologist and/or endocrinologist to find the best treatment for you. They can also go over the latest medications approved for treatment. According to Ilya Leyngold, MD, an oculofacial surgeon in Meridien, Idaho, there is currently a lot of ongoing research dedicated to improving treatment options for people with thyroid eye disease. “The goal in the future is centered on minimizing the costs and improving how the drugs are administered,” says Dr. Leyngold.
The Takeaway
Thyroid eye disease is a chronic condition that requires monitoring with regular checkups. The disorder can be managed with treatments to help reduce and control symptoms. And research will continue to expand ways to help people preserve their vision and reduce their risk of complications.

Edmund Tsui, MD
Medical Reviewer
Edmund Tsui, MD, is an assistant professor of ophthalmology at the Jules Stein Eye Institute in the David Geffen School of Medicine at UCLA.
He earned his medical degree from Dartmouth. He completed an ophthalmology residency at the NYU Grossman School of Medicine, where he was chief resident, followed by a fellowship in uveitis and ocular inflammatory disease at the Francis I. Proctor Foundation for Research in Ophthalmology at the University of California in San Francisco.
Dr. Tsui is committed to advancing the field of ophthalmology. His research focuses on utilizing state-of-the-art ophthalmic imaging technology to improve the diagnosis and monitoring of uveitis. He is a co-investigator in several multicenter clinical trials investigating therapeutics for uveitis. He is the author of over 80 peer-reviewed publications and has given talks at national and international conferences.
Along with his clinical and research responsibilities, Tsui teaches medical students and residents. He is on the Association for Research in Vision and Ophthalmology's professional development and education committee, as well as the advocacy and outreach committee, which seeks to increase funding and awareness of vision research. He also serves on the editorial board of Ophthalmology and the executive committee of the American Uveitis Society.

Jessica Migala
Author
Jessica Migala is a freelance writer with over 15 years of experience, specializing in health, nutrition, fitness, and beauty. She has written extensively about vision care, diabetes, dermatology, gastrointestinal health, cardiovascular health, cancer, pregnancy, and gynecology. She was previously an assistant editor at Prevention where she wrote monthly science-based beauty news items and feature stories.
She has contributed to more than 40 print and digital publications, including Cosmopolitan, O:The Oprah Magazine, Real Simple, Woman’s Day, Women’s Health, Fitness, Family Circle, Health, Prevention, Self, VICE, and more. Migala lives in the Chicago suburbs with her husband, two young boys, rescue beagle, and 15 fish. When not reporting, she likes running, bike rides, and a glass of wine (in moderation, of course).
- Graves’ Disease. National Institute of Diabetes and Digestive and Kidney Diseases. November 2021.
- Thyroid Eye Disease. American Thyroid Association.
- Thyroid Eye Disease. National Organization for Rare Disorders. March 21, 2024.
- Phelps PO. Thyroid Eye Disease. American Academy of Ophthalmology. July 9, 2024.
- Thyroid Eye Disease (Graves’ Disease). Penn Medicine.
- Graves’ Disease. Cleveland Clinic. July 6, 2022.
- Thyroid Eye Disease (TED or Graves Eye Disease). Kellogg Eye Center University of Michigan Health.
- Thyroid Eye Disease. Cleveland Clinic. September 28, 2022.
- Lanzolla G et al. Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease. Frontiers in Endocrinology. January 2021.
- Sobel RK et al. Orbital Radiation for Thyroid Eye Disease: A Report by the American Academy of Ophthalmology. Ophthalmology. April 2022.
- Graves’ Eye Disease. National Eye Institute. November 15, 2023.
- Thyroid Eye Disease. Penn Medicine.
- Hartford J. Exposure Keratopathy. American Academy of Ophthalmology. March 5, 2024.
- Shah SS et al. Thyroid Eye Disease. StatPearls. May 22, 2023.
- Gupta R et al. Thyroid Eye Disease and Its Association With Diabetes Mellitus: A Major Review. Ophthalmic Plastic and Reconstructive Surgery. December 2023.
- Barbesino G et al. Future Projections in Thyroid Eye Disease. The Journal of Clinical Endocrinology & Metabolism. September 2022.